Fecal Incontinence
Conditions
Brief summary
The purpose of this study is to determine whether tibial nerve stimulation is an effective treatment for faecal incontinence.
Detailed description
Faecal incontinence is a common problem, affecting approximately 2% of the adult general population. Initial management involves dietary advice, anti-diarrhoeal medication, and behavioural therapy. In those who have not benefited from these conservative techniques sacral nerve stimulation is an established and effective treatment for faecal incontinence. This treatment involves using electrical pulses to stimulate the S3 nerve root - a nerve at the bottom of the back. These are the nerves which supply the lower end of the bowel, and the anal sphincter. It is believed that it is stimulation of the sensory fibres heading back towards the spinal cord at this level which is important for the therapeutic effect. To stimulate the sacral nerves however requires two operations under general anaesthetic, and surgical implantation of an expensive nerve stimulator. The tibial nerve also contains fibres that arise from the S3 part of the spinal cord. Electrical stimulation of the tibial nerve will therefore send sensory information back to the same region of the spinal cord as sacral nerve stimulation. The tibial nerve is much more easily accessible on the inside of the ankle, and this allows stimulation to be carried out as an outpatient and without the need for surgery. It can be performed either percutaneously (with a fine needle placed through the skin to sit next to the nerve), or transcutaneously. Tibial nerve stimulation has been successfully used for patients with urinary incontinence. There are small studies looking at tibial nerve stimulation for faecal incontinence which both show a benefit, but these studies are not controlled. We aim to determine in a randomised controlled trial whether either percutaneous or transcutaneous tibial nerve stimulation is an effective treatment for faecal incontinence.
Interventions
Once weekly for 30 minutes
30 minutes once weekly
Once weekly for 30 minutes
Sponsors
Uroplasty, Inc
London North West Healthcare NHS Trust
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Over 18 * Incontinence to solid or liquid faeces
Exclusion criteria
* Previous congenital or acquired spinal injury, spinal tumour or spinal surgery * Neurological diseases, such as diabetic neuropathy, multiple sclerosis and Parkinson's disease * Peripheral vascular disease * Diabetes mellitus * Congenital anorectal malformations * Previous rectal surgery (rectopexy / resection) done \< 12 months ago (24 months for cancer) * Present evidence of external full thickness rectal prolapse * Chronic bowel diseases such as inflammatory bowel disease * Chronic diarrhoea, uncontrolled by drugs or diet * Anatomical limitations that would prevent successful placement of an electrode * Previous use of transcutaneous electrical nerve stimulation Stoma in situ
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference in the percentage of patients with a 20% reduction in episodes of faecal incontinence between the placebo and treatment groups. | 14 weeks |
Secondary
| Measure | Time frame |
|---|---|
| The difference in the improvements in the St Mark's incontinence score, quality of life scales, and physiological parameters between the treatment and placebo groups. | 14 weeks |
| The difference in the improvements in the urinary symptoms between placebo and treatment groups. | 14 weeks |
Countries
United Kingdom
Contacts
Primary ContactJames Hollingshead, MRCS
Outcome results
None listed